Ritholtz Wealth Management Amneal Pharmaceuticals, Inc. Transaction History
Ritholtz Wealth Management
- $3.37 Billion
- Q4 2024
A detailed history of Ritholtz Wealth Management transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ritholtz Wealth Management holds 122,473 shares of AMRX stock, worth $1.08 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
122,473
Previous 135,551
9.65%
Holding current value
$1.08 Million
Previous $1.13 Million
14.02%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding AMRX
# of Institutions
190Shares Held
140MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$192 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$129 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$109 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$99.5 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$94.6 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.34B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...